CRYOLIFE INC (CRY) Fundamental Analysis & Valuation

NYSE:CRY

Current stock price

17.88
+0.25 (+1.42%)
At close:
17.88
0 (0%)
After Hours:

This CRY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CRY Profitability Analysis

1.1 Basic Checks

  • In the past year CRY was profitable.
CRY Yearly Net Income VS EBIT VS OCF VS FCFCRY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 10M -10M 20M

1.2 Ratios

Industry RankSector Rank
ROA -0.16%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRY Yearly ROA, ROE, ROICCRY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 2 -2 4 -4

1.3 Margins

Industry RankSector Rank
OM 4.83%
PM (TTM) -0.37%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRY Yearly Profit, Operating, Gross MarginsCRY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CRY Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, CRY has more shares outstanding
  • The debt/assets ratio for CRY is higher compared to a year ago.
CRY Yearly Shares OutstandingCRY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 10M 20M 30M
CRY Yearly Total Debt VS Total AssetsCRY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 200M 400M 600M

2.2 Solvency

  • CRY has an Altman-Z score of 1.67. This is a bad value and indicates that CRY is not financially healthy and even has some risk of bankruptcy.
  • CRY has a Debt/Equity ratio of 1.00. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 1.67
ROIC/WACCN/A
WACCN/A
CRY Yearly LT Debt VS Equity VS FCFCRY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 4.21 indicates that CRY has no problem at all paying its short term obligations.
  • CRY has a Quick Ratio of 2.93. This indicates that CRY is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 4.21
Quick Ratio 2.93
CRY Yearly Current Assets VS Current LiabilitesCRY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. CRY Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 130.77% over the past year.
  • Measured over the past years, CRY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.92% on average per year.
  • CRY shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.55%.
  • Measured over the past years, CRY shows a quite strong growth in Revenue. The Revenue has been growing by 11.66% on average per year.
EPS 1Y (TTM)130.77%
EPS 3Y-16.84%
EPS 5Y8.92%
EPS Q2Q%-138.46%
Revenue 1Y (TTM)40.55%
Revenue growth 3Y10.1%
Revenue growth 5Y11.66%
Sales Q2Q%10.87%

3.2 Future

  • Based on estimates for the next years, CRY will show a very strong growth in Earnings Per Share. The EPS will grow by 40.29% on average per year.
  • The Revenue is expected to grow by 11.66% on average over the next years. This is quite good.
EPS Next Y-91.22%
EPS Next 2Y-45.89%
EPS Next 3Y-4.23%
EPS Next 5Y40.29%
Revenue Next Year18.02%
Revenue Next 2Y14.54%
Revenue Next 3Y12.88%
Revenue Next 5Y11.66%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CRY Yearly Revenue VS EstimatesCRY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CRY Yearly EPS VS EstimatesCRY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

0

4. CRY Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 59.60 indicates a quite expensive valuation of CRY.
  • The average S&P500 Price/Earnings ratio is at 26.78. CRY is valued rather expensively when compared to this.
  • The Price/Forward Earnings ratio is 265.53, which means the current valuation is very expensive for CRY.
  • When comparing the Price/Forward Earnings ratio of CRY to the average of the S&P500 Index (23.54), we can say CRY is valued expensively.
Industry RankSector Rank
PE 59.6
Fwd PE 265.53
CRY Price Earnings VS Forward Price EarningsCRY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.14
CRY Per share dataCRY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • CRY's earnings are expected to decrease with -4.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)6.68
EPS Next 2Y-45.89%
EPS Next 3Y-4.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CRY Dividend Analysis

5.1 Amount

  • CRY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CRY Fundamentals: All Metrics, Ratios and Statistics

CRYOLIFE INC

NYSE:CRY (1/21/2022, 8:51:04 PM)

After market: 17.88 0 (0%)

17.88

+0.25 (+1.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)02-10
Inst Owners91.55%
Inst Owner Change2.05%
Ins Owners5.73%
Ins Owner Change0%
Market Cap703.22M
Revenue(TTM)358.43M
Net Income(TTM)-1.33M
Analysts82.5
Price Target33.09 (85.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 59.6
Fwd PE 265.53
P/S 1.96
P/FCF N/A
P/OCF N/A
P/B 2.26
P/tB N/A
EV/EBITDA 23.14
EPS(TTM)0.3
EY1.68%
EPS(NY)0.07
Fwd EY0.38%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.11
BVpS7.92
TBVpSN/A
PEG (NY)N/A
PEG (5Y)6.68
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.16%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 4.83%
PM (TTM) -0.37%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.21
Quick Ratio 2.93
Altman-Z 1.67
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)130.77%
EPS 3Y-16.84%
EPS 5Y8.92%
EPS Q2Q%-138.46%
EPS Next Y-91.22%
EPS Next 2Y-45.89%
EPS Next 3Y-4.23%
EPS Next 5Y40.29%
Revenue 1Y (TTM)40.55%
Revenue growth 3Y10.1%
Revenue growth 5Y11.66%
Sales Q2Q%10.87%
Revenue Next Year18.02%
Revenue Next 2Y14.54%
Revenue Next 3Y12.88%
Revenue Next 5Y11.66%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CRYOLIFE INC / CRY Fundamental Analysis FAQ

What is the fundamental rating for CRY stock?

ChartMill assigns a fundamental rating of 4 / 10 to CRY.


What is the valuation status of CRYOLIFE INC (CRY) stock?

ChartMill assigns a valuation rating of 1 / 10 to CRYOLIFE INC (CRY). This can be considered as Overvalued.


Can you provide the profitability details for CRYOLIFE INC?

CRYOLIFE INC (CRY) has a profitability rating of 4 / 10.


What is the valuation of CRYOLIFE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CRYOLIFE INC (CRY) is 59.6 and the Price/Book (PB) ratio is 2.26.


What is the earnings growth outlook for CRYOLIFE INC?

The Earnings per Share (EPS) of CRYOLIFE INC (CRY) is expected to decline by -91.22% in the next year.